Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL120P is a pseudogene derived from the RNA, 7SL, cytoplasmic gene family, specifically referencing a non-functional, sequence variant or truncated copy of the 7SL RNA gene[2][4][7]. Most 7SL pseudogenes in the human genome are the result of reverse transcription and reintegration events; they do not encode active RNAs or proteins and lack known biological functions. The active form, 7SL RNA, is a critical component of the signal recognition particle (SRP) ribonucleoprotein complex and is involved in cotranslational protein targeting to the endoplasmic reticulum[1][5][6][8]. However, the RN7SL120P locus itself is regarded as non-functional and is not associated with specific therapeutic targeting, disease involvement, biological processes, drug interactions, or biomarker status[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 120, pseudogene (RN7SL120P).